Teresa's husband was diagnosed with ALS. She spent 11 years as his caregiver and discusses her experiences.
Resources
-
February 05, 2019
-
January 30, 2019
Onpattro (patisiran) is a first-in-class treatment that slows down the progression of hereditary transthyretin amyloidosis (hATTR).
-
January 30, 2019
After failing to show a clear benefit over chemotherapy on its own, both the FDA and EMA do not recommend Lartruvo (olaratumab) for use in combination with chemotherapy for new STS patients.
-
January 25, 2019
Realistic new year's resolutions for lasting results!
-
January 18, 2019
Over 50 countries have approved Spinraza (nusinersen), but not all have made it available to the patients who need it.
-
January 14, 2019
New medicine shows statistically significant improvements for prostate cancer patients.
-
January 08, 2019
We are looking for an outstanding Web Developer to be responsible for the coding, innovative design and layout of our website.
-
December 20, 2018
A new biosimilar, Truxima (rituximab), shows comparable results to the reference medicine, Rituxan (rituximab), and takes FDA one step further toward expanding patient access to medicines.
-
December 18, 2018
Our team shares their take on what we do at TheSocialMedwork.
-
December 17, 2018
Positive news for patients with early-stage FAP; results from a Portuguese study show that a liver transplant or Vyndaqel may extend survivability.
-
December 14, 2018
Zolgensma (onasemnogene abeparvovec-xxxx) to receive priority review by FDA as a one-time treatment of type 1 spinal muscular atrophy (SMA).
-
December 03, 2018
Australia provides reimbursement for cystic fibrosis medicine.
-
November 30, 2018
The European Commission has approved Alunbrig (brigatinib) for the treatment of a specific type of lung cancer.
-
November 29, 2018
A late-stage study testing Bavencio (avelumab) has failed to meet its primary endpoints in patients with certain forms of ovarian cancer.
-
November 29, 2018
In an exploratory study Ocrevus (ocrelizumab) slowed down loss of function in the upper extremities for patients with primary progressive multiple sclerosis (PPMS).
-
November 21, 2018
Doctors hold the key to access new medicines.
-
November 14, 2018
How we find and ship medicines on behalf of patients.
-
October 21, 2018
-
October 03, 2018
-
October 03, 2018
-
October 03, 2018
-
September 17, 2018
How two professors imagine a better world for stakeholders in the medical industry.
-
September 17, 2018
"These results offer a leap in understanding about this disease that provides a genetically based framework for designing clinical trials to develop more effective treatments of MPAL,"
-
September 17, 2018
"In short, it will help produce drugs where we can be far more confident about where modifications are being made, so that side effects can be minimized in the future"
-
September 10, 2018
Understand why approval doesn’t necessarily mean availability and what you can do if a medicine is approved, but not available in your country.
-
August 31, 2018
Dying to Survive’ was an unlikely blockbuster, documenting the plight of a leukemia patient who puts himself at risk to import costly cancer drugs for himself and his fellow countrymen.
-
August 31, 2018
Researchers report a successful classification of triple breast cancer patients, which for the first time, would allow doctors to discern between those who can be cured and those who might suffer a relapse.
-
According to study investigators, about a third of patients could benefit from this therapy that may offer remissions, relieve symptoms and save lives.
-
"This is a great avenue of exploration, particularly for the 30 percent of children who struggle or don't make it with standard therapy."
-
August 30, 2018
These findings increase our understanding of how the brain is affected by Parkinson's disease...